The WHO recommendations encourage the adoption of those technologies, provided they are often validated to exhibit equal or excellent general performance in comparison to regular approaches. Manufacturers wanting to put into action these techniques will have to supply strong validation knowledge to demonstrate their equivalence to pharmacopoeial strategies. A waiting for link from Forum Profiles (11)